日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Voice EHR: introducing multimodal audio data for health

语音电子病历:引入多模态音频数据用于健康管理

Anibal, James; Huth, Hannah; Li, Ming; Hazen, Lindsey; Daoud, Veronica; Ebedes, Dominique; Lam, Yen Minh; Nguyen, Hang; Hong, Phuc Vo; Kleinman, Michael; Ost, Shelley; Jackson, Christopher; Sprabery, Laura; Elangovan, Cheran; Krishnaiah, Balaji; Akst, Lee; Lina, Ioan; Elyazar, Iqbal; Ekawati, Lenny; Jansen, Stefan; Nduwayezu, Richard; Garcia, Charisse; Plum, Jeffrey; Brenner, Jacqueline; Song, Miranda; Ricotta, Emily; Clifton, David; Thwaites, C Louise; Bensoussan, Yael; Wood, Bradford

Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure

ixekizumab治疗银屑病关节炎患者的安全性:来自四项临床试验、超过2000患者年的暴露数据。

Deodhar, Atul A; Combe, Bernard; Accioly, Ana P; Bolce, Rebecca; Zhu, Danting; Gellett, Amanda M; Sprabery, Aubrey Trevelin; Burmester, Gerd-Rüdiger R

Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials

伊克珠单抗治疗银屑病关节炎男性和女性患者的疗效:两项随机3期临床试验的结果

Eder, Lihi; Tony, Hans-Peter; Odhav, Satish; Agirregoikoa, Eva Galindez; Korkosz, Mariusz; Schwartzman, Sergio; Sprabery, Aubrey Trevelin; Gellett, Amanda M; Park, So Young; Bertram, Clinton C; Ogdie, Alexis

Treatment patterns and health care costs among patients with psoriatic arthritis treated with biologic or targeted synthetic disease-modifying antirheumatic drugs

使用生物制剂或靶向合成疾病修饰抗风湿药物治疗银屑病关节炎患者的治疗模式和医疗保健费用

Murage, Mwangi J; Princic, Nicole; Park, Julie; Malatestinic, William N; Zhu, Baojin; Atiya, Bilal; Kern, Scott A; Stenger, Keri B; Sprabery, Aubrey Trevelin; Ogdie, Alexis

Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies

伊克珠单抗(无论是否联合甲氨蝶呤)可改善银屑病关节炎的体征和症状:Spirit-P1 和 Spirit-P2 研究的第 52 周结果

Combe, Bernard; Tsai, Tsen-Fang; Huffstutter, J Eugene; Sprabery, Aubrey Trevelin; Lin, Chen-Yen; Park, So Young; Kronbergs, Andris; Hufford, Matthew M; Nash, Peter

Improvement from ixekizumab treatment in patients with psoriatic arthritis who have had an inadequate response to one or two TNF inhibitors

对一种或两种 TNF 抑制剂反应不足的银屑病关节炎患者,ixekizumab 治疗可改善病情

Kirkham, Bruce; Sesin, Carlos; Gellett, Amanda M; Sprabery, Aubrey T; Lin, Chen-Yen; Turkiewicz, Anthony

Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)

伊克珠单抗治疗对 TNF 抑制剂反应不足的银屑病关节炎患者的疗效和安全性:3 年随访 (SPIRIT-P2)

Orbai, Ana-Maria; Gratacós, Jordi; Turkiewicz, Anthony; Hall, Stephen; Dokoupilova, Eva; Combe, Bernard; Nash, Peter; Gallo, Gaia; Bertram, Clinton C; Gellett, Amanda M; Sprabery, Aubrey Trevelin; Birt, Julie; Macpherson, Lisa; Geneus, Vladimir J; Constantin, Arnaud

Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study

伊克珠单抗治疗银屑病关节炎患者的真实世界治疗模式和医疗保健成本:一项回顾性研究

Murage, Mwangi J; Princic, Nicole; Park, Julie; Malatestinic, William; Zhu, Baojin; Atiya, Bilal; Kern, Scott A; Stenger, Keri B; Sprabery, Aubrey Trevelin; Ogdie, Alexis

Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)

伊克珠单抗治疗未接受过生物制剂治疗的活动性银屑病关节炎患者:一项 III 期临床试验 (SPIRIT-P1) 的 3 年结果

Chandran, Vinod; van der Heijde, Désirée; Fleischmann, Roy M; Lespessailles, Eric; Helliwell, Philip S; Kameda, Hideto; Burgos-Vargas, Ruben; Erickson, Janelle S; Rathmann, Suchitrita S; Sprabery, Aubrey Trevelin; Birt, Julie A; Shuler, Catherine L; Gallo, Gaia

Impact of Enthesitis on Psoriatic Arthritis Patient-Reported Outcomes and Physician Satisfaction with Treatment: Data from a Multinational Patient and Physician Survey

肌腱附着点炎对银屑病关节炎患者报告结局和医生治疗满意度的影响:一项多国患者和医生调查的数据

Orbai, Ana-Maria; Birt, Julie A; Holdsworth, Elizabeth A; Booth, Nicola; Malatestinic, William N; Sprabery, Aubrey T; Reginato, Anthony M